IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300

REFERENCES

• Agarwal, C., S. Dhanalakshmi, R. Singh, and R. Agarwal. 2003. Inositol hexaphosphate inhibits constitutive activation of NF-κB in androgen-independent human prostate carcinoma DU145 cells. Anticancer Res. 23:3855–3861.
   PubMedGoogle Scholar
• Aguilera, C., R. Hoya-Arias, G. Haegeman, L. Espinosa, and A. Bigas. 2004. Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA 101:16537–16542.
   PubMed Web of Science ®Google Scholar
• Anders, R. A., L. M. Yerian, M. Tretiakova, J. M. Davison, R. J. Quigg, P. H. Domer, J. Hoberg, and J. Hart. 2003. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am. J. Pathol. 162:991–1000.
   PubMedGoogle Scholar
• Anest, V., J. L. Hanson, P. C. Cogswell, K. A. Steinbrecher, B. D. Strahl, and A. S. Baldwin. 2003. A nucleosomal function for IκB kinase α in NF-κB-dependent gene expression. Nature 423:659–663.
   PubMed Web of Science ®Google Scholar
• Anest, V., P. C. Cogswell, and A. S. Baldwin, Jr. 2004. IκB kinase α and p65/RelA contribute to optimal epidermal growth factor-induced c-fos gene expression independent of IκBα degradation. J. Biol. Chem. 279:31183–31189.
   PubMedGoogle Scholar
• Ashburner, B. P., S. D. Westerheide, and A. S. Baldwin, Jr. 2001. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21:7065–7077.
   PubMed Web of Science ®Google Scholar
• Baek, S. H., K. A. Ohgi, D. W. Rose, E. H. Koo, C. K. Glass, and M. G. Rosenfeld. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and beta-amyloid precursor protein. Cell 110:55–67.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–681.
   PubMed Web of Science ®Google Scholar
• Bohuslav, J., L. F. Chen, H. Kwon, Y. Mu, and W. C. Greene. 2004. p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279:26115–26125.
   PubMed Web of Science ®Google Scholar
• Burstein, E., and C. S. Duckett. 2003. Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr. Opin. Cell Biol. 15:732–737.
   PubMed Web of Science ®Google Scholar
• Buss, H., A. Dorrie, M. L. Schmitz, R. Frank, M. Livingstone, K. Resch, and M. Kracht. 2004. Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity. J. Biol. Chem. 279:49571–49574.
   PubMed Web of Science ®Google Scholar
• Buss, H., A. Dorrie, M. L. Schmitz, E. Hoffmann, K. Resch, and M. Kracht. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKK-β, IKK-ε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279:55633–55643.
   PubMed Web of Science ®Google Scholar
• Campbell, K. J., S. Rocha, and N. D. Perkins. 2004. Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB. Mol. Cell 13:853–865.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653–1657.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., and W. C. Greene. 2003. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 81:549–557.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21:6539–6548.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., S. A. Williams, Y. Mu, H. Nakano, J. M. Duerr, L. Buckbinder, and W. C. Green. 2005. NF-κB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966–7975.
   PubMed Web of Science ®Google Scholar
• Codina, A., J. D. Love, Y. Li, M. A. Lazar, D. Neuhaus, and J. W. R. Schwabe. 2005. Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 102:6009–6014.
   PubMedGoogle Scholar
• De Ruijter, A. J. M., A. H. Van Gennip, H. N. Caron, S. Kemp, and A. B. P. Van Kuilenburg. 2003. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 370:737–749.
   PubMed Web of Science ®Google Scholar
• Duran, A., M. T. Diaz-Meco, and J. Moscat. 2003. Essential role of RelA ser311 phosphorylation by ζPKC in NF-κB transcriptional activation. EMBO J. 22:3910–3918.
   PubMed Web of Science ®Google Scholar
• Fischle, W., F. Dequiedt, M. J. Hendzel, M. G. Guenther, M. A. Lazar, W. Voelter, and E. Verdin. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9:45–57.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109:S81–S96.
   PubMed Web of Science ®Google Scholar
• Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21:6091–6101.
   PubMed Web of Science ®Google Scholar
• Guenther, M. G., J. Yu, G. D. Kao, T. J. Yen, and M. A. Lazar. 2002. Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev. 16:3130–3135.
   PubMed Web of Science ®Google Scholar
• Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18:2195–2224.
   PubMed Web of Science ®Google Scholar
• Hoberg, J. E., F. Yeung, and M. W. Mayo. 2004. SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol. Cell 16:245–255.
   PubMed Web of Science ®Google Scholar
• Holmes-McNary, M. and A. S. Baldwin, Jr. 2000. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60:3477–3483.
   PubMed Web of Science ®Google Scholar
• Hu, J., H. Nakano, H. Sakurai, and N. H. Colburn. 2004. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis 25:1991–2003.
   PubMedGoogle Scholar
• Jepsen, K., and M. G. Rosenfeld. 2002. Biological roles and mechanistic actions of co-repressor complexes. J. Cell Sci. 115:689–698.
   PubMed Web of Science ®Google Scholar
• Jiang, X., N. Takahashi, N. Matsui, T. Tetsuka, and T. Okamoto. 2003. The NF-κB activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278:919–926.
   PubMed Web of Science ®Google Scholar
• Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621–623.
   PubMed Web of Science ®Google Scholar
• Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221–227.
   PubMed Web of Science ®Google Scholar
• Kiernan, R., V. Bres, R. W. M. Ng, M. P. Coudart, S. El Messaoudi, C. Sardet, D. Y. Jin, S. Emiliani, and M. Benkirane. 2003. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758–2766.
   PubMed Web of Science ®Google Scholar
• Lawrence, T., M. Bebien, G. Y. Liu, V. Nizet, and M. Karin. 2005. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434:1138–1143.
   PubMed Web of Science ®Google Scholar
• Lee, S. K., J. H. Kim, Y. C. Lee, J. Cheong, and J. W. Lee. 2000. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-κB, and serum response factor. J. Biol. Chem. 275:12470–12474.
   PubMedGoogle Scholar
• Manna, S. K., A. Mukhopadhyay, and B. B. Aggarwal. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:6509–6519.
   PubMed Web of Science ®Google Scholar
• Mattioli, I., A. Sebald, C. Bucher, R. P. Charles, H. Nakano, T. Doi, M. Kracht, and M. L. Schmitz. 2004. Transient and selective NF-κB p65 serine 536 phosphorylation induced by T cell costimulation is mediated by IκB kinase β and controls the kinetics of p65 nuclear import. J. Immunol. 172:6336–6344.
   PubMed Web of Science ®Google Scholar
• Mayo, M. W., and A. S. Baldwin. 2000. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470:M55–M62.
   PubMedGoogle Scholar
• Mayo, M. W., C. E. Denlinger, R. M. Broad, F. Yeung, E. T. Reilly, Y. Shi, and D. R. Jones. 2003. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway. J. Biol. Chem. 278:18980–18989.
   PubMed Web of Science ®Google Scholar
• Mayo, M., and D. Jones. 2004. Dynamic regulation of NF-κB transcriptional activity via recruitment of co-activator and co-repressor complexes. Mechanisms of signal transduction and inducible gene expression. Research Signpost Publisher, Tivandrum, Kerala, India.
   Google Scholar
• Metivier, R., G. Penot, M. R. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751–763.
   PubMed Web of Science ®Google Scholar
• Na, S. Y., S. K. Lee, S. J. Han, H. S. Choi, S. Y. Im, and J. W. Lee. 1998. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor κB-mediated transactivations. J. Biol. Chem. 273:10831–10834.
   PubMedGoogle Scholar
• Nakajima, H., P. K. Brindle, M. Handa, and J. N. Ihle. 2001. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J. 20:6836–6844.
   PubMedGoogle Scholar
• Natoli, G., S. Saccani, D. Bosisio, and I. Marazzi. 2005. Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6:439–445.
   PubMed Web of Science ®Google Scholar
• Okazaki, T., S. Sakon, T. Sasazuki, H. Sakurai, T. Doi, H. Yagita, K. Okumura, and H. Nakano. 2003. Phosphorylation of serine-276 is essential for p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300:807–812.
   PubMedGoogle Scholar
• O'Mahony, A. M., M. Montano, K. Van Beneden, L. F. Chen, and W. C. Greene. 2004. Human T-cell lymphotropic virus type 1 Tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 279:18137–18145.
   PubMedGoogle Scholar
• Park, K. J., V. Krishnan, B. W. O'Malley, Y. Yamamoto, and R. B. Gaynor. 2005. Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol. Cell 18:71–82.
   PubMed Web of Science ®Google Scholar
• Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511–526.
   PubMed Web of Science ®Google Scholar
• Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:21096–21103.
   PubMed Web of Science ®Google Scholar
• Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12:4685–4695.
   PubMedGoogle Scholar
• Rocha, S., M. Garrett, K. J. Campbell, K. Schumm, and N. D. Perkins. 2005. Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumor suppressor. EMBO J. 24:1157–1169.
   PubMedGoogle Scholar
• Rocha, S., K. J. Campbell, and N. D. Perkins. 2003. p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor. Mol. Cell. 12:15–25.
   PubMed Web of Science ®Google Scholar
• Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403:103–118.
   PubMed Web of Science ®Google Scholar
• Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell. 12:1413–1426.
   PubMed Web of Science ®Google Scholar
• Saccani, S., I. Marazzi, A. A. Beg, and G. Natoli. 2004. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J. Exp. Med. 200:107–113.
   PubMedGoogle Scholar
• Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353–30356.
   PubMed Web of Science ®Google Scholar
• Sakurai, H., S. Suzuki, N. Kawasaki, H. Nakano, T. Okazaki, A. Chino, T. Doi, and I. Saiki. 2003. Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278:36916–36923.
   PubMed Web of Science ®Google Scholar
• Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805–3817.
   PubMed Web of Science ®Google Scholar
• Sheppard, K. A., K. M. Phelps, A. J. Williams, D. Thanos, C. K. Glass, M. G. Rosenfeld, M. E. Gerritsen, and T. Collins. 1998. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273:29291–29294.
   PubMed Web of Science ®Google Scholar
• Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19:6367–6378.
   PubMed Web of Science ®Google Scholar
• Silverman, N., and T. Maniatis. 2001. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2321–2342.
   PubMed Web of Science ®Google Scholar
• Smith, C. L., and B. W. O'Malley. 2004, Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25:45–71.
   PubMed Web of Science ®Google Scholar
• Vermeulen, L., G. De Wilde, P. V. Damme, W. Vanden Berghe, and G. Haegeman. 2003. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22:1313–1324.
   PubMed Web of Science ®Google Scholar
• Wang, D., S. D. Westerheide, J. L. Hanson, and A. S. Baldwin, Jr. 2000. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275:32592–32597.
   PubMed Web of Science ®Google Scholar
• Werbajh, S., I. Nojek, R. Lanz, and M. A. Costas. 2000. RAC-3 is a NF-κB coactivator. FEBS Lett. 485:195–199.
   PubMedGoogle Scholar
• Wu, R. C., J. Qin, Y. Hashimoto, J. Wong, J. Xu, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 2002. Regulation of SRC-3 (Pcip/Actr/Aib-1/Rag-3/Tram-1) coactivator activity by IκB kinase. Mol. Cell. Biol. 22:3549–3561.
   PubMedGoogle Scholar
• Yamamoto, Y., U. N. Verma, S. Prajapati, Y. T. Kwak, and R. B. Gaynor. 2003. Histone H3 phosphorylation by IKKα is critical for cytokine-induced gene expression. Nature 423:655–659.
   PubMed Web of Science ®Google Scholar
• Yang, F., E. Tang, K. Guan, and C. Y. Wang. 2003. IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170:5630–5635.
   PubMed Web of Science ®Google Scholar
• Yeung, F., J. E. Hoberg, C. S. Ramsey, M. D. Keller, D. R. Jones, R. Frye, and M. W. Mayo. 2004. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369–2380.
   PubMed Web of Science ®Google Scholar
• Yin, M. J., Y. Yamamoto, and R. B. Gaynor. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396:77–80.
   PubMed Web of Science ®Google Scholar
• Yu, J. Y. Ki, T. Ishizuka, M. G. Guenther, and M. A. Lazar. 2003. A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J. 22:3403–3410.
   PubMed Web of Science ®Google Scholar
• Zhong, H. H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC1. Mol. Cell 9:625–636.
   PubMed Web of Science ®Google Scholar